Keywords: Sodium-glucose co-transporter-2 inhibitors; Disproportionality; FAERS; Pharmacovigilance; Signal;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: FAERS Search; Sphincter of Oddi Dysfunction; Functional Gastrointestinal Disorders; IBS; FAERS; Federal Adverse Event Reporting System; FDA; Food and Drug Administration; IBS-D; diarrhea-predominant irritable bowel syndrome; SOD; sphincter of Oddi dysfunc
Keywords: Dental equipment; dental public health; dental records; informatics; quality of care; safety management; AEs; Adverse events; AHRQ; Agency for Healthcare Research and Quality; DC; District of Columbia; FAERS; FDA Adverse Event Reporting System; FDA; Food
Keywords: Postmarketing safety; Adverse events; FDA; Medical devices; Biological products; Surveillance; FAERS; MAUDE
Keywords: acne vulgaris; acne vulgaris/drug therapy; dermatologic agents/adverse effects; inflammatory bowel diseases; inflammatory bowel diseases/chemically induced; isotretinoin; postmarketing; product surveillance; FAERS; Food and Drug Administration Adverse Eve
SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation
Keywords: Stevens-Johnson; Toxic epidermal necrolysis; HLA; Networks; Pharmacogenomics; Pharmacovigilance; Electronic health record; T cells; Granulysin; ADR; Adverse drug reaction; AMT; Amniotic membrane transplantation; BSA; Body surface area; CPNDS; Canadian Pha
CiPA challenges and opportunities from a non-clinical, clinical and regulatory perspectives. An overview of the safety pharmacology scientific discussion
Keywords: Comprehensive In-Vitro Proarrhythmia assay; CiPA; hERG; Multiple cardiac ion channels; Proarrhythmia; QTc; Torsade de pointes; AV; atrioventricular; CiPA; Comprehensive In-Vitro Proarrhythmia Assay; CSRC; Cardiac Safety Research Consortium; DG; Discussion
Original ArticlesChemical Leukoderma Associated with Methylphenidate Transdermal System: Data From the US Food and Drug Administration Adverse Event Reporting System
Keywords: attention deficit hyperactivity disorder; depigmentation; hypopigmentation; vitiligo; skin discoloration; ADHD; Attention deficit-hyperactivity disorder; FAERS; FDA Adverse Event Reporting System; FDA; Food and Drug Administration; MedDRA; Medical Diction
Finding a Needle in a QT Interval Big Data Haystack
Keywords: adverse drug reactions; electronic health records; FAERS; HERG; long QT syndrome;
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System
Keywords: Dipeptidyl peptidase-4 inhibitors; Sitagliptin; Saxagliptin; Heart failure; Drug safety; Disproportionality; Spontaneous reporting system; FAERS
Coupling Data Mining and Laboratory Experiments to Discover Drug Interactions Causing QT Prolongation
Keywords: data mining; data science; drug-drug interaction; long QT syndrome; APD70; action potential duration at 70% of repolarization; DDI; drug-drug interaction; ECG; electrocardiogram; EHR; electronic health records; FAERS; Food and Drug Administration adverse
Peripheral neuropathy and Guillain-Barré syndrome risks associated with exposure to systemic fluoroquinolones: a pharmacovigilance analysis
Keywords: Guillain-Barré syndrome; Peripheral neuropathy; Fluoroquinolones; Pharmacovigilance; FAERS; Disproportionality analysis
Adverse drug and device reactions in the oral cavity
Keywords: Epidemiology; consumer product safety; drugs; U.S. Food and Drug Administration; implants; legal liability; oral medicine; postmarketing product surveillance; safety management; AE; Adverse effect; FAERS; FDA Adverse Event Reporting System; FDA; Food and